Switch to:

Denali Therapeutics Cash Flow for Dividends

: $0.0 Mil (TTM As of Sep. 2019)
View and export this data going back to 2017. Start your Free Trial

Denali Therapeutics's cash flow for dividends for the three months ended in Sep. 2019 was $0.0 Mil. Its cash flow for dividends for the trailing twelve months (TTM) ended in Sep. 2019 was $0.0 Mil.

Note: A negative number here means the payment of dividends. When pays more dividends, the absolute value gets bigger.


Denali Therapeutics Cash Flow for Dividends Historical Data

* All numbers are in millions except for per share data and ratio. All numbers are in their local exchange's currency.

* Premium members only.

Denali Therapeutics Annual Data
Dec15 Dec16 Dec17 Dec18
Cash Flow for Dividends 0.00 0.00 0.00 0.00

Denali Therapeutics Quarterly Data
Dec15 Dec16 Mar17 Jun17 Sep17 Dec17 Mar18 Jun18 Sep18 Dec18 Mar19 Jun19 Sep19
Cash Flow for Dividends Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

Denali Therapeutics Cash Flow for Dividends Calculation

Cash flow for dividends refers to the payment of cash to shareholders as dividends when the company generates income.

Cash Flow for Dividends for the trailing twelve months (TTM) ended in Sep. 2019 was 0 (Dec. 2018 ) + 0 (Mar. 2019 ) + 0 (Jun. 2019 ) + 0 (Sep. 2019 ) = $0.0 Mil.

* All numbers are in millions except for per share data and ratio. All numbers are in their local exchange's currency.


Denali Therapeutics Cash Flow for Dividends Related Terms


Denali Therapeutics Cash Flow for Dividends Headlines

No Headline

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)